HomeXLO • NASDAQ
Xilio Therapeutics Inc
add
$0.80
5.88%
Pre-market:(1.25%)-0.0100
$0.79
Closed: May 16, 5:36:51 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.93M | — |
Operating expense | 8.52M | -48.52% |
Net income | -13.27M | 22.89% |
Net profit margin | -452.73 | — |
Earnings per share | — | — |
EBITDA | -13.44M | 16.50% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 89.07M | 162.13% |
Total assets | 103.72M | 25.55% |
Total liabilities | 93.02M | 63.63% |
Total equity | 10.70M | — |
Shares outstanding | 74.70M | — |
Price to book | 6.07 | — |
Return on assets | -39.62% | — |
Return on capital | -190.05% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -13.27M | 22.89% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$0.85
Day range
$0.78 - $0.86
Year range
$0.62 - $1.70
Market cap
41.43M USD
Avg Volume
1.82M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
64
